BaeHR, LeungPS, TsuneyamaK, et al.Chronic expression of IFN-γ leads to murine autoimmune cholangitis with a female predominance. Hepatology, 2016; 64(4):1189–1201; doi: 10.1002/hep.28641.
2.
BaeHR, LeungPSC, HodgeDL, et al.Multi-omics: Differential expression of IFN-γ results in distinctive mechanistic features linking chronic inflammation, gut dysbiosis, and autoimmune diseases. J Autoimmun, 2020; 111:102436; doi: 10.1016/j.jaut.2020.102436.
3.
BorchardtSM, RitgerKA, DworkinMS. Categorization, prioritization, and surveillance of potential bioterrorism agents. Infect Dis Clin North Am, 2006; 20(2):213–225; doi: 10.1016/j.idc.2006.02.005.
4.
BurkeJD, YoungHA. IFN-γ: A cytokine at the right time, is in the right place. Semin Immunol, 2019; 43:101280; doi: 10.1016/j.smim.2019.05.002.
5.
ChoiJ, MeleTS, PorcelliSA, et al.Harnessing the versatility of invariant NKT cells in a stepwise approach to sepsis immunotherapy. J Immunol, 2021; 206(2):386–397; doi: 10.4049/jimmunol.2000220.
6.
DellabonaP, PeccoudJ, KapplerJ, et al.Superantigens interact with MHC class II molecules outside of the antigen groove. Cell, 1990; 62(6):1115–1121; doi: 10.1016/0092-8674(90)90388-u.
7.
HayworthJL, MazzucaDM, Maleki VarekiS, et al.CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens. Immunol Cell Biol, 2012; 90(7):699–709; doi: 10.1038/icb.2011.90.
8.
HodgeDL, BerthetC, CoppolaV, et al.IFN-γ AU-rich element removal promotes chronic IFN-γ expression and autoimmunity in mice. J Autoimmun, 2014; 53:33–45; doi: 10.1016/j.jaut.2014.02.003.
9.
KhabarKS, YoungHA. Post-transcriptional control of the interferon system. Biochimie, 2007; 89(6–7):761–769; doi: 10.1016/j.biochi.2007.02.008.
LinFC, KarwanM, SalehB, et al.IFN-γ causes aplastic anemia by altering hematopoietic stem/progenitor cell composition and disrupting lineage differentiation. Blood, 2014; 124(25):3699–3708; doi: 10.1182/blood-2014-01-549527.
12.
MillerCH, MaherSG, YoungHA. Clinical use of IFN-γ. Ann N Y Acad Sci, 2009; 1182(1):69–79; doi: 10.1111/j.1749-6632.2009.05069.x.
13.
SavanR, RavichandranS, CollinsJR, et al.Structural conservation of interferon γ among vertebrates. Cytokine Growth Factor Rev, 2009; 20(2):115–124; doi: 10.1016/j.cytogfr.2009.02.006.
14.
ShalerCR, ChoiJ, RudakPT, et al.MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression. PLoS Biol, 2017; 15(6):e2001930; doi: 10.1371/journal.pbio.2001930.
15.
SzaboPA, GoswamiA, MazzucaDM, et al.Rapid and rigorous IL-17A production by a distinct subpopulation of effector memory T lymphocytes constitutes a novel mechanism of toxic shock syndrome immunopathology. J Immunol, 2017a;198(7):2805–2818; doi: 10.4049/jimmunol.1601366.
16.
SzaboPA, RudakPT, ChoiJ, et al.Invariant natural killer T cells are pathogenic in the HLA-DR4-transgenic humanized mouse model of toxic shock syndrome and can be targeted to reduce morbidity. J Infect Dis, 2017b;215(5):824–829; doi: 10.1093/infdis/jiw646.
17.
TuffsSW, HaeryfarSMM, McCormickJK. Manipulation of innate and adaptive immunity by staphylococcal superantigens. Pathogens, 2018; 7(2):53; doi: 10.3390/pathogens7020053.
YoungHA, BreamJH. IFN-γ: Recent advances in understanding regulation of expression, biological functions, and clinical applications. Curr Top Microbiol Immunol, 2007; 316:97–117; doi: 10.1007/978-3-540-71329-6_6.
22.
YoungHA, GhoshP. Molecular regulation of cytokine gene expression: Interferon-γ as a model system. Prog Nucleic Acid Res Mol Biol, 1997; 56:109–127; doi: 10.1016/s0079-6603(08)61004-1.
23.
YoungHA, HardyKY. Role of interferon-γ in immune cell regulation. J Leukoc Biol, 1995; 58(4):373–381.
